Response · adults with Major Depressive Disorder
It is very uncertain whether vortioxetine changes response compared with SNRIs (very low certainty).
1 finding from 1 review
Total number of drop‐outs · adults with Major Depressive Disorder
It is very uncertain whether vortioxetine changes total number of drop‐outs compared with SNRIs (very low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
It is very uncertain whether S‐adenosyl methionine as adjunctive treatment changes acceptability Participants dropping out of treatment during the… compared with placebo (very low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · depression in adults
S‐adenosyl methionine as monotherapy showed no clear difference in acceptability Participants dropping out of treatment during the… compared with placebo (low certainty).
1 finding from 1 review
Acceptability. Participants experiencing troublesome adverse effects of any nature · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability. Participants experiencing troublesome adverse effects of any nature · depression in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total number of drop‐outs · patients with depression
Dance Movement Therapy (DMT) showed no clear difference in drop‐outs drop‐out numbers in each arm compared with standard care or waiting list control (low certainty).
1 finding from 1 review
Social and occupational functioning · patients with depression
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · patients with depression
1 finding from 1 review
Self-esteem (Piers-Harris self-concept scale) · patients with depression
1 finding from 1 review
Intervention not reported
Response rate at post‐treatment (as defined in individual studies) · women with postnatal depression
It is very uncertain whether the intervention changes response rate at post‐treatment (as defined in individual studies) (very low certainty).
1 finding from 1 review
Intervention not reported
Remission rate at post‐treatment (as defined in individual studies) · women with postnatal depression
It is very uncertain whether the intervention changes remission rate at post‐treatment (as defined in individual studies) (very low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · patients with depression
Paroxetine showed no clear difference in failure to respond at endpoint (6‐12 weeks) compared with older ADs (moderate certainty).
1 finding from 1 review
Failure to respond at 16‐24 weeks · patients with depression
1 finding from 1 review
Failure to respond at 1‐4 weeks · patients with depression
Paroxetine probably leads to lower failure to respond at 1‐4 weeks compared with reboxetine (moderate certainty).
1 finding from 1 review
Failure to respond at 16‐24 weeks · patients with depression
1 finding from 1 review
Failure to remit at endpoint · patients with depression
1 finding from 1 review
SMD at endpoint · patients with depression
1 finding from 1 review
Failure to complete ‐ any cause ‐ · patients with depression
Paroxetine showed no clear difference in failure to complete ‐ any cause ‐ compared with reboxetine (moderate certainty).
1 finding from 1 review
Participants with at least some Side Effects · patients with depression
Paroxetine showed no clear difference in participants with at least some Side Effects compared with reboxetine (moderate certainty).
1 finding from 1 review